Mesoblast reported higher Ryoncil revenue, record September patient starts and a sharp fall in cash spend in preliminary figures.
Mesoblast reported higher Ryoncil revenue, record September patient starts and a sharp fall in cash spend in preliminary figures.This article was originally published by Kalkine Media.
Read Full Story on Source Site →